Aging and neurodegeneration are closely linked, as age is one of the most significant risk factors for many neurological diseases. Neurodegeneration involves the progressive loss of structure or function of neurons, leading to conditions such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS). As the global population ages, the burden of these diseases continues to grow, making prevention and treatment critical priorities. The Aging and Neurodegeneration session will explore mechanisms of neurodegenerative diseases, recent advances in diagnostic technologies, and innovative therapies aimed at slowing disease progression. This session will also address the public health impact of neurodegeneration worldwide.

Neurologists, geriatric specialists, neuroscientists, caregivers, and students participating in neurodegeneration conferences will find this session highly valuable. It is also relevant for researchers studying aging and companies developing therapeutic solutions. By attending, participants will gain a comprehensive understanding of disease pathways, prevention strategies, and patient-centered care approaches.